A regulação do setor farmacêutico no âmbito da administração pública: uma análise da produção normativa da CMED
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Over the course of two decades, many normative acts were published by CMED with the aim
of fulfilling the main task established in Law No. 10,742/03, which established the Chamber,
which deals with the definition of regulatory standards to be applied to the pharmaceutical
sector and the promotion of assistance. pharmaceutical sector to the population through
mechanisms that stimulate the supply of medicines and competition in the sector. Thus, given
the long period of validity of the legal diploma and CMED's unprecedented initiative in
promoting the review of Resolution No. 2/2004, this being the most significant normative act
produced by the Chamber for approving the criteria for defining maximum prices allowed for
the commercialization of new medicines and new presentations in our country, academic
interest in the normative production of CMED was awakened. Thus, with the aim of
contributing to the production of scientific knowledge in the field of regulation and normative
production within the scope of public administration, especially that produced by CMED, this
empirical research sought to understand and answer the following research question:
considering the published Resolutions by the Council of Ministers of the Medicines Market
Regulation Chamber, what were the most representative changes in their respective contents in
relation to the Resolutions prior to Law No. 10,742/03 establishing CMED? As theoretical
bases for the investigation, the teachings of the author Zenon Bankowski were used, therefore,
through theory and understanding the relationship between the morality of duty and the morality
of aspiration, it was possible to better understand the regulatory process and normative
production of the Chamber of Medicines Regulation (CMED) linked to ANVISA. Furthermore,
empirical research based on the rules of inference developed by Lee Epstein and Gary King
was used methodologically. Finally, it was concluded that CMED has an important social
function in promoting greater access for the population to medicines and that the rules contained
in Law No. 10,742/03, observed by the body, are, in fact, necessary to prevent errors of
regulation that occurred in the past are not repeated again. Furthermore, it was found that
CMED does in fact have a large normative production compared to previous legislation from
the Chamber of Medicines (CAMED), information, empirical data absent in the texts researched
relating to the pharmaceutical sector.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

